The alga Euglena gracilis stimulates Faecalibacterium in the gut and contributes to increased defecation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 29 08 2020
accepted: 18 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 13 8 2021
Statut: epublish

Résumé

The alga Euglena gracilis (E. gracilis) has recently gained attention as a health food, but its effects on human gut microbiota remain unknown. This study aimed to determine the effect of E. gracilis on gut microbiota and defecation due to modulation of microbiota composition in vitro and in vivo. The in vitro model simulating human colonic microbiota revealed that E. gracilis addition stimulated the growth of commensal Faecalibacterium. Further, E. gracilis addition enhanced butyrate production by Faecalibacterium prausnitzii. Paramylon, an insoluble dietary fibre that accumulates in E. gracilis and is the main component of E. gracilis, did not stimulate Faecalibacterium growth in vitro. Daily ingestion of 2 g of E. gracilis for 30 days increased bowel movement frequency as well as stool volume in 28 human participants. Collectively, these findings indicate that E. gracilis components other than paramylon, stimulate the growth of Faecalibacterium to improve digestive health as well as promote defecation by increasing butyrate production.

Identifiants

pubmed: 33441865
doi: 10.1038/s41598-020-80306-0
pii: 10.1038/s41598-020-80306-0
pmc: PMC7806897
doi:

Substances chimiques

Butyrates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1074

Références

Nutrients. 2019 Jan 21;11(1):
pubmed: 30669573
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Pharmacol Res. 2010 Mar;61(3):219-25
pubmed: 19914380
Biotechnol J. 2019 May;14(5):e1800555
pubmed: 30791234
Front Immunol. 2018 Aug 15;9:1830
pubmed: 30158926
Sci Rep. 2017 Aug 1;7(1):7046
pubmed: 28765642
Microb Biotechnol. 2017 Sep;10(5):1017-1024
pubmed: 28809450
Nutrients. 2019 May 22;11(5):
pubmed: 31121913
Food Funct. 2013 Nov;4(11):1685-90
pubmed: 24104447
Bioinformatics. 2011 Aug 15;27(16):2194-200
pubmed: 21700674
PLoS One. 2018 Feb 15;13(2):e0192404
pubmed: 29447191
Adv Exp Med Biol. 2017;979:285-293
pubmed: 28429327
Food Funct. 2016 Nov 9;7(11):4655-4659
pubmed: 27775129
J Vet Med Sci. 2010 Jun;72(6):755-63
pubmed: 20160419
Curr Opin Microbiol. 2013 Jun;16(3):255-61
pubmed: 23831042
Front Bioeng Biotechnol. 2019 May 15;7:108
pubmed: 31157220
BMC Bioinformatics. 2008 Sep 19;9:386
pubmed: 18803844
Microb Ecol Health Dis. 2015 Feb 04;26:26164
pubmed: 25656825
FEMS Microbiol Lett. 2015 Nov;362(21):
pubmed: 26420851
Diabetes. 2009 Jul;58(7):1509-17
pubmed: 19366864
PLoS One. 2014 Aug 21;9(8):e105592
pubmed: 25144201
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Nat Rev Genet. 2012 Mar 13;13(4):260-70
pubmed: 22411464
BMC Vet Res. 2017 Nov 15;13(1):335
pubmed: 29141637
Immunity. 2018 May 15;48(5):992-1005.e8
pubmed: 29768180
J Vet Med Sci. 2009 Jul;71(7):885-90
pubmed: 19652474
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
World J Gastroenterol. 2012 Dec 28;18(48):7378-83
pubmed: 23326148
Prz Gastroenterol. 2013;8(5):295-8
pubmed: 24868272
Appl Environ Microbiol. 1993 Mar;59(3):695-700
pubmed: 7683183
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):503-14
pubmed: 20664519
BMC Gastroenterol. 2015 Aug 11;15:100
pubmed: 26261039
Int J Mol Sci. 2019 Dec 19;21(1):
pubmed: 31861663
Arch Microbiol. 2015 Sep;197(7):919-34
pubmed: 26068535
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):379-383
pubmed: 28974421

Auteurs

Ayaka Nakashima (A)

The Research and Development Department, euglena Co., Ltd., Tokyo, 108-0014, Japan. nakashima@euglena.jp.

Kengo Sasaki (K)

Graduate School of Science, Technology, and Innovation, Kobe University, Kobe, Hyogo, 657-8501, Japan. sikengo@people.kobe-u.ac.jp.

Daisuke Sasaki (D)

Graduate School of Science, Technology, and Innovation, Kobe University, Kobe, Hyogo, 657-8501, Japan.

Kosuke Yasuda (K)

The Research and Development Department, euglena Co., Ltd., Tokyo, 108-0014, Japan.

Kengo Suzuki (K)

The Research and Development Department, euglena Co., Ltd., Tokyo, 108-0014, Japan.

Akihiko Kondo (A)

Graduate School of Science, Technology, and Innovation, Kobe University, Kobe, Hyogo, 657-8501, Japan.
RIKEN Center for Sustainable Resource Science, Yokohama, Kanagawa, 230-0045, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH